These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 27122510)

  • 21. Atypical diaphyseal femoral fractures: Considerations on surgical technique.
    Spinelli MS; Marini E; Daolio PA; Piccioli A
    Injury; 2019 Jul; 50 Suppl 2():S65-S69. PubMed ID: 30782394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trabecular Bone Score and Hip Structural Analysis in Patients With Atypical Femur Fractures.
    Buitendijk SKC; van de Laarschot DM; Smits AAA; Koromani F; Rivadeneira F; Beck TJ; Zillikens MC
    J Clin Densitom; 2019; 22(2):257-265. PubMed ID: 29661684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current Understanding of Epidemiology, Pathophysiology, and Management of Atypical Femur Fractures.
    Starr J; Tay YKD; Shane E
    Curr Osteoporos Rep; 2018 Aug; 16(4):519-529. PubMed ID: 29951870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bisphosphonate treatment and the risk of atypical femoral fracture among patients participating in a Fracture Liaison Service of a tertiary medical center.
    Bareli N; Gat R; Makarov V; Siris E; Fraenkel M; Yoel U
    Arch Osteoporos; 2021 Jun; 16(1):86. PubMed ID: 34089098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atypical femoral fractures and bisphosphonate treatment: experience in two large United Kingdom teaching hospitals.
    Thompson RN; Phillips JR; McCauley SH; Elliott JR; Moran CG
    J Bone Joint Surg Br; 2012 Mar; 94(3):385-90. PubMed ID: 22371548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical characteristics, densitometric parameters and outcomes of patients with atypical femoral fractures related to bisphosphonate treatment for osteoporosis.
    Wong CH; Kan AKC; Tsoi KH; Chan SSY; Jiang NS; Loong CHN; Fong CHY; Wong JSH; Shea GKH; Cheung CL; Lee CH; Tan KCB; Woo YC; Lui DTW
    Endocrine; 2024 Apr; 84(1):223-235. PubMed ID: 37985574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical femur fractures: 81 individual personal histories.
    Schneider JP; Hinshaw WB; Su C; Solow P
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4324-8. PubMed ID: 23076349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Audit of Atypical Femoral Fractures and a Description of Some of Their Features.
    Lian K; Trollip J; Sandhu S; Moosavi M; Gill A; Kendler D; Dian L; Lentle B
    Can Assoc Radiol J; 2016 Feb; 67(1):69-75. PubMed ID: 26800621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitivity and specificity of radiographic characteristics in atypical femoral fractures.
    Adams AL; Xue F; Chantra JQ; Dell RM; Ott SM; Silverman S; Giaconi JC; Critchlow C
    Osteoporos Int; 2017 Jan; 28(1):413-417. PubMed ID: 27766369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying atypical femoral fractures--a retrospective review.
    Juby AG; Crowther S; Cree M
    Calcif Tissue Int; 2014 Nov; 95(5):405-12. PubMed ID: 25209972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atypical Femoral Fracture in Rheumatoid Arthritis Patients Treated With Bisphosphonates: A Nested Case-Control Study.
    Koh JH; Myong JP; Jung SM; Lee J; Kwok SK; Park SH; Ju JH
    Arthritis Rheumatol; 2016 Jan; 68(1):77-82. PubMed ID: 26360133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of bone microarchitecture in postmenopausal women on long-term bisphosphonate therapy with atypical fractures of the femur.
    Zanchetta MB; Diehl M; Buttazzoni M; Galich A; Silveira F; Bogado CE; Zanchetta JR
    J Bone Miner Res; 2014 Apr; 29(4):999-1004. PubMed ID: 24115250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of atypical femoral fracture during and after bisphosphonate use.
    Schilcher J; Koeppen V; Aspenberg P; Michaƫlsson K
    Acta Orthop; 2015 Feb; 86(1):100-7. PubMed ID: 25582459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atypical subtrochanteric and femoral shaft fractures and possible association with bisphosphonates.
    Nieves JW; Cosman F
    Curr Osteoporos Rep; 2010 Mar; 8(1):34-9. PubMed ID: 20425089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of bisphosphonate and non-bisphosphonate related atypical femoral fracture in a South East Asian population - Secondary analysis.
    Gani LU; Anthony NF; Dacay LM; Tan PT; Chong LR; King TFJ
    Bone; 2022 Sep; 162():116455. PubMed ID: 35688361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association of race/ethnicity and risk of atypical femur fracture among older women receiving oral bisphosphonate therapy.
    Lo JC; Hui RL; Grimsrud CD; Chandra M; Neugebauer RS; Gonzalez JR; Budayr A; Lau G; Ettinger B
    Bone; 2016 Apr; 85():142-7. PubMed ID: 26769007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone cross-sectional geometry is not associated with atypical femoral fractures in Asian female chronic bisphosphonate users.
    Chou AC; Ng AC; Png MA; Chua DT; Ng DC; Howe TS; Koh JS
    Bone; 2015 Oct; 79():170-5. PubMed ID: 26067179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bisphosphonates and the risk of atypical femur fractures.
    Black DM; Condra K; Adams AL; Eastell R
    Bone; 2022 Mar; 156():116297. PubMed ID: 34920168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The outcome of surgically treated femur fractures associated with long-term bisphosphonate use.
    Weil YA; Rivkin G; Safran O; Liebergall M; Foldes AJ
    J Trauma; 2011 Jul; 71(1):186-90. PubMed ID: 21610533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increasing occurrence of atypical femoral fractures associated with bisphosphonate use.
    Meier RP; Perneger TV; Stern R; Rizzoli R; Peter RE
    Arch Intern Med; 2012 Jun; 172(12):930-6. PubMed ID: 22732749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.